HR-9937-119
Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by Marlin Stutzman (R-IN)
What it does
This bill would reduce the drug quantity thresholds that trigger mandatory minimum sentences for fentanyl and its analogues under federal law — by a factor of 20 — meaning smaller amounts would qualify for the same 5-year and 10-year mandatory minimums that currently apply to much larger quantities. It would also expand coverage to include both scheduled and unscheduled fentanyl analogues. Additionally, the bill would direct the U.S. Postal Service to deploy more chemical screening devices and trained personnel to detect fentanyl and other synthetic opioids in the mail, and would authorize $9 million for that purpose.
Who benefits
Communities and families affected by fentanyl overdoses, who may see reduced drug supply if interdiction and sentencing deter trafficking. Law enforcement agencies that would gain clearer statutory authority to prosecute smaller-quantity fentanyl cases. The U.S. Postal Service, which would receive additional resources and equipment. Prosecutors seeking longer sentences for fentanyl distributors. Competing drug trafficking organizations whose rivals face harsher penalties.
Who is hurt
Individuals convicted of fentanyl offenses involving smaller quantities who would now face mandatory minimum sentences they previously would not have. Defense attorneys and defendants who lose judicial discretion at sentencing. People who use fentanyl and may face harsher penalties for possession-adjacent conduct. Postal workers who may face new screening responsibilities. Civil liberties organizations concerned about mandatory minimum expansion. Taxpayers who would fund increased incarceration costs and the $9 million appropriation. Federal public defenders facing a larger caseload of mandatory minimum cases.
Supporters argue
Supporters argue that fentanyl is exponentially more potent than heroin — a lethal dose can be as small as 2 milligrams — making the existing quantity thresholds dangerously out of step with the drug's actual harm. They contend that the current thresholds, designed for less potent opioids, allow mid-level fentanyl traffickers to escape mandatory minimums that were intended to target serious dealers, and that the 2023 CDC data showing over 70,000 fentanyl-involved overdose deaths annually demonstrates the urgency of stronger deterrence and interdiction.
Opponents argue
Opponents argue that decades of research — including DOJ's own studies — show mandatory minimums do not meaningfully deter drug trafficking and instead result in lengthy sentences for low-level couriers and people with substance use disorders rather than kingpins. They contend that reducing thresholds by a factor of 20 would sweep in a far broader population of defendants, disproportionately affecting low-income individuals and communities of color, while doing little to disrupt the supply chains of large trafficking organizations whose leaders rarely handle drugs directly.